Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy (Q74261230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

I M Wakelkamp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M N Gerding

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J W Van Der Meer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M F Prummel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

W M Wiersinga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

453-457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy

9 November 2019

cites work

1 reference

12 December 2020

Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia

1 reference

12 December 2020

Smoking and risk of Graves' disease

1 reference

12 December 2020

Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy

1 reference

12 December 2020

Pathogenesis of Graves' ophthalmopathy

1 reference

12 December 2020

Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists

1 reference

12 December 2020

Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy

1 reference

12 December 2020

Graves' ophthalmopathy: current concepts regarding pathogenesis and management

1 reference

12 December 2020

Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue

1 reference

12 December 2020

HLA-DPB1 polymorphisms in patients with hyperthyroid Graves' disease and early onset myasthenia gravis

1 reference

12 December 2020

Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy

1 reference

12 December 2020

CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.

1 reference

12 December 2020

Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines

1 reference

12 December 2020

Pathogenesis of Graves' ophthalmopathy: recent controversies and progress

1 reference

12 December 2020

Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment

1 reference

12 December 2020

CD30-mediated signaling promotes the development of human T helper type 2-like T cells

1 reference

12 December 2020

Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy

1 reference

12 December 2020

Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease

1 reference

12 December 2020

Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis

1 reference

12 December 2020

Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy.

1 reference

12 December 2020

Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO).

1 reference

12 December 2020

Anti-heat shock protein (hsp)72 antibodies are present in patients with Graves' disease (GD) and in smoking control subjects

1 reference

12 December 2020

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy

1 reference

12 December 2020

The use of colour slides in the assessment of changes in soft-tissue involvement in Graves' ophthalmopathy

1 reference

12 December 2020

Immunohistochemical and Ultrastructural Studies on the Exenterated Orbital Tissues of a Patient with Graves' Disease

1 reference

12 December 2020

Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.

1 reference

12 December 2020

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach

1 reference

12 December 2020

Connective tissue, glycosaminoglycans, and diseases of the thyroid

1 reference

12 December 2020

Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy

1 reference

12 December 2020

Association between Graves' ophthalmopathy and smoking

1 reference

12 December 2020

SERUM SOLUBLE INTERLEUKIN 2 RECEPTOR IN HYPERTHYROID Graves'DISEASE AND EFFECT OF CARBIMAZOLE THERAPY

1 reference

12 December 2020

Thyroid-associated eye disease: pathophysiology

1 reference

12 December 2020

Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy

1 reference

12 December 2020

The effect of carbimazole therapy on interleukin 2, interleukin 2 receptors and free radicals

1 reference

12 December 2020

Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin

1 reference

12 December 2020

Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts

1 reference

12 December 2020

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

12 December 2020

Soluble IL-2 receptor levels in patients with Graves'ophthalmopathy

1 reference

12 December 2020

Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts

1 reference

12 December 2020

10.1046/J.1365-2249.2000.01335.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971510%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference